Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta ‐analysis
ConclusionsTAVR is an effective and safe procedure in CA-AS patients, with a substantial survival benefit as compared with medical therapy, and a safety profile comparable with patients with AS alone except for a trend towards higher risk of permanent pacemaker implantation.
Source: ESC Heart Failure - Category: Cardiology Authors: Francesco Cannata,
Mauro Chiarito,
Giuseppe Pinto,
Alessandro Villaschi,
Jorge Sanz ‐Sánchez,
Fabio Fazzari,
Damiano Regazzoli,
Antonio Mangieri,
Renato M. Bragato,
Antonio Colombo,
Bernhard Reimers,
Gianluigi Condorelli,
Giulio G. Stefanin Tags: Original Article Source Type: research
More News: Amyloidosis | Aortic Stenosis | Bleeding | Cardiology | Heart | Heart Failure | Heart Valve Surgery | Stroke | Study | Urology & Nephrology